News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Beatrix Taylor, BSc, MSc

Articles by Beatrix Taylor, BSc, MSc

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

ByRobert Alexander, MD,Jasna Hocevar-Trnka, MD, MPH,Nathan Bryson, PhD,Beatrix Taylor, BSc, MSc

June 26th 2024

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

Latest Updated Articles

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression
Published: June 26th 2024 | Updated:

Trending on Psychiatric Times

November in Review: Updates on the Psychiatric Treatment Pipeline

A Not So Happy Third Birthday for ChatGPT

Thank Goodness for Psychiatry!

Bromine and Bromism: What’s Old Is New Again

Prescription Digital Therapeutics for Substance Use Disorders: Insights from Alejandro Alva, MD

© 2025 MJH Life Sciences^®

All rights reserved.